A Phase II Trial of Split, Low-Dose Docetaxel and Low-Dose Capecitabine: A Tolerable and Efficacious Regimen in the First-Line Treatment of Patients with HER2/neu–Negative Metastatic Breast Cancer

2008 ◽  
Vol 8 (2) ◽  
pp. 162-167 ◽  
Author(s):  
Orlando Silva ◽  
Gilberto Lopes ◽  
Daniel Morgenzstern ◽  
Christopher Lobo ◽  
Philomena Doliny ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Low Dose ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment

A Phase II Trial of Vinflunine As Monotherapy or in Combination with Trastuzumab as First-Line Treatment of Metastatic Breast Cancer

2010 ◽  
Vol 28 (9) ◽  
pp. 925-931 ◽  
Author(s):  
Denise A. Yardley ◽  
Michael McCleod ◽  
Fred Schreiber ◽  
Patrick Murphy ◽  
Jeffrey Patton ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment

Phase II trial of weekly nab-paclitaxel in combination with bevacizumab as first-line treatment in metastatic breast cancer

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 1075-1075 ◽  
Author(s):  
M. A. Danso ◽  
J. L. Blum ◽  
N. J. Robert ◽  
L. Krekow ◽  
R. Rotche ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment

Phase II Trial of Weekly Docetaxel, Vinorelbine, and Trastuzumab in the First-Line Treatment of Patients with HER2-Positive Metastatic Breast Cancer

2009 ◽  
Vol 9 (1) ◽  
pp. 23-28 ◽  
Author(s):  
Jeffrey R. Infante ◽  
Denise A. Yardley ◽  
Howard A. Burris ◽  
F. Anthony Greco ◽  
Cindy P. Farley ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
Line Treatment ◽  
First Line ◽  
Her2 Positive ◽  
Weekly Docetaxel ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document